Nearly half a million people with diabetes end up in emergency rooms around the US every year due to the seizures and other consequences of dropping or spiking blood-sugar levels associated with the disease, researchers said.
To help prevent serious complications, scientists have developed the new glucose-sensing protein that could one day be part of an implantable monitoring device.
Most patients with diabetes track glucose levels by using a glucose metre. They prick a finger with a tiny needle to draw blood, which they apply to a test strip inserted into the metre.
As a result, many patients don't test their blood as often as they should, risking complications such as seizures.
More From This Section
For more continuous monitoring, some patients use implantable devices that measure blood-sugar as often as once a minute, but they have drawbacks.
They are expensive, can only be used for up to a week and are not as reliable as conventional metres.
The new study focused on a protein that has already been explored as a good candidate for use in a continuous glucose monitoring system. It's a glucose/galactose binding protein (GBP) that changes shape when it attaches to glucose.
The study was published in the journal ACS Chemical Biology.